MicroPort Cardiac Rhythm Management Limited (MicroPort CRM), a subsidiary of Hong Kong-listed Chinese medical device developer MicroPort, has inked a deal to raise $150 million in a Series C round of financing from investors including Hillhouse Capital.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in